Neurent Medical
About
Neurent Medical is a Galway-based medtech company developing the NEUROMARK device, which uses proprietary Impedance Controlled Radiofrequency technology to target overactive posterior nasal nerves and treat chronic rhinitis — a condition affecting over 500 million people globally. Founded in 2015, the company closed an oversubscribed €62.5 million Series C in February 2026, led by MVM Partners with participation from Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, and Enterprise Ireland, bringing total funding to over €100 million.
Investors and backers 2
- Atlantic BridgeVenture Capital · Dublin
- Fountain Healthcare PartnersAccelerator · Dublin
Connection map
Every node here is a row in the lists above — the map is a second view of the same connections, not another source of them.